Documentos relacionados

1. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
2. Heavy Metal Enlightens Tumor Immunity.
3. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
4. Molecular differences in renal cell carcinoma between males and females.
5. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
6. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
7. Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma.
8. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
9. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
10. Renal cell carcinoma, part 1.